U.S. Endoscopy Video Processor Market Report 2022-2028: High Incidence of Gastrointestinal Cancer Driving Sector Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Endoscopy Video Processor Market, by Product Type, by Application, by End User – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering. Market Dynamics High incidence of gastrointestinal cancer is anticipated to drive the growth of the U.S. endoscopy video processor market over the forecast … [Read more…]

DG Solutions Names Industry Veteran Ghiaseddin President

Healthcare Insider to Lead Data Integrity, Robustness, Security Initiatives CONYERS, Ga.–(BUSINESS WIRE)–DG Solutions (www.dgsolutionsinc.com), a prominent technology partner to the healthcare industry, is pleased to announce that seasoned veteran Pooya Ghiaseddin has assumed the role of company president. In his new role, Ghiaseddin will lead the expansion of DG Solutions’ corporate strategies including a sharp … [Read more…]

Diagnostics Demystified By New “It’s Not Magic, It’s Diagnostics” Campaign

Halteres Associates marks their 20th anniversary by launching a new website to educate the public about diagnostic testing through advancing industry innovation SAN RAMON, Calif.–(BUSINESS WIRE)–Halteres Associates today announced the launch of their new “It’s Not Magic, It’s Diagnostics” website, a resource developed by the firm to advocate for the diagnostics and clinical laboratory industries … [Read more…]

Neuraptive Therapeutics Announces First Patient Enrolled in a Phase 2 Trial of NTX-001 for the Prevention of Facial Paralysis and Provides Update on the Phase 2 Study of NTX-001 in Peripheral Nerve Injuries due to Trauma

– Facial Paralysis Prevention study initiated and first patient enrolled evaluating the safety and efficacy of NTX-001 following facial nerve surgery – Ongoing Trauma Phase 2 study hits enrollment milestone with topline data expected in 2nd half of 2023 PHILADELPHIA–(BUSINESS WIRE)–Neuraptive Therapeutics, Inc. (Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical … [Read more…]

Tinnitus Pipeline Research Report 2022: Comprehensive Insights About 8+ Companies and 8+ Pipeline Drugs – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Tinnitus – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. The publisher’s, “Tinnitus – Pipeline Insight, 2022,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Tinnitus pipeline landscape. A detailed picture of the Tinnitus pipeline landscape is provided which includes the disease overview and Tinnitus treatment … [Read more…]

Innovaderm Shines as Key Partner in Clinical Development and Study Management of Newly FDA-Approved Psoriasis Drug, Tapinarof

MONTREAL–(BUSINESS WIRE)–#DermatologyCRO–Innovaderm’s involvement in all phases of the clinical development of tapinarof culminated with a tremendous achievement: the recent approval of Dermavant Sciences’ VTAMA® (tapinarof) cream by the FDA for the treatment of plaque psoriasis in adults. Discovered in Canada, tapinarof is approved in the United States for the management of psoriasis, a chronic skin … [Read more…]

Stephen J. Thomas, M.D., Joins Rheonix Board and Executive Team

New addition to Rheonix leadership adds expertise in infectious diseases and global epidemic response ITHACA, N.Y.–(BUSINESS WIRE)–Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, announced the appointment of Stephen J. Thomas, M.D., as Chief Medical Officer and member of the Rheonix Board of Directors. “I am delighted to welcome Dr. Thomas to the … [Read more…]

Ozgene and Gen-H partner on Ozgene’s new OzBIG targeted humanization capability

PERTH, Australia & HEIDELBERG, Germany–(BUSINESS WIRE)–#biotechnology–Ozgene and Gen-H are pleased to announce our working partnership supporting Ozgene’s new OzBIG capability. Ozgene Pty Ltd is a privately held CRO based in Perth, Australia providing custom genetically engineered mice for academic and commercial researchers worldwide. Gen-H GmbH is a privately held CRO based in Heidelberg, Germany providing … [Read more…]

GE Healthcare Unveils Latest Ultra-Premium Ultrasound in Women’s Health Portfolio

Voluson Expert 22 represents a major step forward in ultrasound innovation from a market leader in Women’s Health Ultrasound Next-generation architecture behind Voluson Expert 22 includes Voluson graphic-based beam former technology; AI powered tools; and customizable touch panel, color and lighting options CHICAGO–(BUSINESS WIRE)–GE Healthcare today unveiled its most advanced ultrasound yet, the next-generation Voluson™ … [Read more…]

Global Biotech Flavors Market Report 2022: Industry Analysis, Trends, Market Size, and Forecasts 2020-2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biotech Flavors Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global biotech flavors market to grow with a significant CAGR over the forecast period from 2022-2028. The report on the global biotech flavors market provides qualitative and quantitative … [Read more…]